SELANK
Unit Size | 5 mg/vial |
Unit Quantity | 1 Vial |
Molecular Formula | C33H57N11O9 |
Molecular Weight | 751.9 |
Sequence | H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH |
Appearance | White Powder |
Peptide Purity | >98.1% |
Solubility | Soluble in water or 1% acetic acid |
Selank, a heptapeptide that serves as an analog to tuftsin, has attracted attention within the pharmacological community for its comprehensive range of effects. By modifying the tuftsin peptide sequence, Selank achieves increased stability and bioavailability, making it more effective for therapeutic use. Its mechanism of action involves the modulation of crucial neurotransmitters such as serotonin, dopamine, and GABA, offering anxiolytic benefits similar to those of benzodiazepines but without the associated sedative and dependency risks.
Beyond its influence on neurotransmitter activity, Selank affects gene expression related to GABA receptors and plays a role in regulating the immune system, particularly through its effects on cytokine production. These properties confer antiviral and immunomodulatory functions to Selank, broadening its potential applications. Clinically, it has been recognized for its anxiolytic, neuroprotective, and cognitive-enhancing effects, presenting a high safety profile and minimal side effects. Its primary route of administration is nasal, which facilitates quick absorption and helps protect it from enzymatic degradation.
Please be aware that the information provided is based on scientific research and is for educational and informational purposes only. It is the subject of ongoing studies to further understand its potential and applications. Individuals should consult healthcare professionals before considering any peptide for therapeutic use.
OFFICIAL PARTNERS: